MK-4541

MK-4541

MK-4541Musculoskeletal diseases
CAS: 796885-38-6
MF: C22H31F3N2O3
MW: 428.49
Indications
Therapeutic Target
Usage

A selective SARM with anti-prostate cancer and pro-myogenic effects.

Specification
>99%
Product Description

Overview

MK-4541 is a dual SARM and 5α-reductase inhibitor, exerting anti-androgenic effects in prostate while anabolic in muscle and bone. It inhibits tumor growth, maintains lean mass during castration, and supports behavior in models. Suited for prostate cancer adjuvant and muscle preservation studies.

Synonyms: Carbamic acid, N-[(4aR,4bS,6aS,7S,9aS,9bS,11aR)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1,4a,6a-trimethyl-2-oxo-1H-indeno[5,4-f]quinolin-7-yl]-, 2,2,2-trifluoroethyl ester

EINECS: 692-949-8

Product Categories: SARM series

Mol File: 796885-38-6.mol

Physicochemical Properties

Boiling point: 522.3±50.0°C(Predicted)

Density: 1.25±0.1g/cm3(Predicted)

MSDS Information

Experimental Data

Pharmacodynamics

Mechanism Of Action